Atlas Trials

Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer

Clinical trial NCT00616122 · TERMINATED

Trial details

NCT number
NCT00616122
Sponsor
University of California, San Francisco
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2006-03-01
Primary completion
2011-03-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.